The full content of Annals is available to subscribers

I am disheartened by the publication of Chou and colleagues' recent review (1), which suggests that PSA screening is ineffective and harmful to U.S. men. I do not believe that the “exhaustive review of the latest evidence” described by the authors is applicable to these men.

The American Cancer Society (2) reports that 35 110 cases of prostate cancer are expected to occur in African American men in 2011 to 2012, accounting for 40% of all types of cancer diagnosed in this group. One in 5 African American men will be diagnosed with prostate cancer in his lifetime.